Sapporo Clinical Laboratory Inc. (JASDAQ:9776) announces a share repurchase program. Under the program, the company will repurchase 45,000 shares, representing 1.3% of the outstanding shares, at ¥2,449 per share for ¥110.21 million. The purpose of the program is to implement a flexible capital policy in response to changes in the business environment. As of June 26, 2018, the company had 3,462,561 shares outstanding and 753,439 shares in treasury.